Invesaro

Stocks Comparison

Cannabis Bioscience International vs Foxo Technologies: revenue, profit, margins and growth compared

Cannabis Bioscience International brought in $303K of revenue in fiscal 2025, Foxo Technologies $16.4M in fiscal 2025. Revenue changed by +21.8% at Cannabis Bioscience International and +304.0% at Foxo Technologies on the year before, so Foxo Technologies grew faster. Cannabis Bioscience International kept -181.1% of its revenue as net profit, Foxo Technologies -75.9%.

Side by side, latest fiscal year

CBIHFOXO
Fiscal year endedFY2025 (May 31, 2025)FY2025 (December 31, 2025)
Revenue$303K$16.4M
Revenue growth+21.8%+304.0%
Net income-$548.8K-$12.4M
Net margin-181.1%-75.9%
Free cash flown/a-$3.9M
Free cash flow marginn/a-24.0%
Earnings per share (diluted)-$0.00n/a
Cash$13K$207.5K
Debt$286.2Kn/a
Price to earningsn/an/a
Market value$1.2M$231.8K
Dividend yieldn/an/a
Rank by revenue in sector#567 of 587 · Industrials#491 of 587 · Industrials

Over the years

Revenue
CBIH FY2024: $316.8KCBIH FY2024: $248.8KCBIH FY2025: $303KFOXO FY2021: $120KFOXO FY2022: $511KFOXO FY2023: $145.3KFOXO FY2024: $4.1MFOXO FY2025: $16.4MFY21FY22FY23FY24FY25
CBIH $303KFOXO $16.4M
Net income
CBIH FY2024: -$1MCBIH FY2024: -$651.3KCBIH FY2025: -$548.8KFOXO FY2021: -$38.5MFOXO FY2022: -$95.3MFOXO FY2023: -$26.5MFOXO FY2024: -$12.4MFOXO FY2025: -$12.4MFY21FY22FY23FY24FY25
CBIH -$548.8KFOXO -$12.4M
Net margin
CBIH FY2024: -325.9%CBIH FY2024: -261.8%CBIH FY2025: -181.1%FOXO FY2021: -32,073.3%FOXO FY2022: -18,640.9%FOXO FY2023: -18,205.2%FOXO FY2024: -306.2%FOXO FY2025: -75.9%FY21FY22FY23FY24FY25
CBIH -181.1%FOXO -75.9%
Revenue growth
CBIH FY2024: -21.5%CBIH FY2025: +21.8%FOXO FY2022: +325.8%FOXO FY2023: -71.6%FOXO FY2024: +2,688.6%FOXO FY2025: +304.0%FY22FY23FY24FY25
CBIH +21.8%FOXO +304.0%
Free cash flow
FOXO FY2021: -$15.2MFOXO FY2022: -$23.9MFOXO FY2025: -$3.9MFY21FY22FY25
CBIHFOXO -$3.9M

Fiscal years as each company reports them; the two may end in different months.

Questions about Cannabis Bioscience International and Foxo Technologies

Which is bigger by revenue, Cannabis Bioscience International or Foxo Technologies?

Foxo Technologies is bigger by revenue: $16.4M in fiscal 2025, against $303K for Cannabis Bioscience International in fiscal 2025.

Which keeps more of its revenue as profit, Cannabis Bioscience International or Foxo Technologies?

Cannabis Bioscience International had a net margin of -181.1% in fiscal 2025; Foxo Technologies had -75.9% in fiscal 2025.

Which grew revenue faster, Cannabis Bioscience International or Foxo Technologies?

In their latest fiscal years revenue changed by +21.8% at Cannabis Bioscience International and +304.0% at Foxo Technologies.

Where do these numbers come from?

From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.

More comparisons

Compare more companies